Letters to the Editor

Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls

Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York
Department of Medicine, University of Iceland
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm
Department of Hematology, Skane University Hospital Malmö/Lund
Department of Chemical Biology, Sloan Kettering Institute, New York
Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York
Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York
Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York
Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York
Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York
Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York
Department of Medicine, University of Iceland, Iceland; Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm
Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami
Haematologica Early view Sep 2, 2021 https://doi.org/10.3324/haematol.2021.278772